Ironwood Pharma Financial Overview
Ironwood Pharma's market cap is currently $311.87M. The company's EPS TTM is $0.23; its P/E ratio is ―; Ironwood Pharma is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
